Skip to main content

Patient Support Line 1-866-433-8000, Monday - Friday: 8:00 AM to 8:00 PM ET

For people with HR+, HER2- stage 2 or stage 3 early breast cancer with a high risk of cancer coming back. Do more today to help protect tomorrow
KISQALI is proven to help reduce the risk of cancer coming back*

*KISQALI + hormone therapy cut the risk of cancer returning by 25% compared to hormone therapy alone. At 3 years, 91% of people taking KISQALI + hormone therapy were cancer-free, compared with 88% of people taking hormone therapy alone.